Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GLP-1 agonist
GLP-1 agonist
New Novo Nordisk Strategy Drops Oral Insulin, Expands Oral GLP-1
Seeking Alpha
Sun, 10/30/16 - 11:14 am
Novo Nordisk
diabetes
oral insulin
insulin
GLP-1 agonist
R&D
Sanofi Should Be Thinking Longer Duration In GLP-1s
Seeking Alpha
Tue, 08/2/16 - 09:09 am
Sanofi
GLP-1 agonist
Adlyxin
Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth
Fierce Pharma
Mon, 07/11/16 - 09:15 am
diabetes
Novo Nordisk
Eli Lilly
GLP-1 agonist
Victoza
Trulicity
Novo Nordisk notches another phase 3 success for GLP-1 drug
BioPharma Dive
Fri, 02/26/16 - 10:18 am
Novo Nordisk
diabetes
GLP-1 agonist
semaglutide
Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster
Seeking Alpha
Fri, 11/27/15 - 11:59 am
Novo Nordisk
diabetes
semaglutide
GLP-1 agonist
Sanofi, Hanmi seal diabetes license deal for up to $4.2 bln
Yahoo/Reuters
Thu, 11/5/15 - 09:47 am
Sanofi
Hanmi Pharma
diabetes
GLP-1 agonist
South Korea
Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal
Fierce Pharma
Wed, 09/16/15 - 06:01 pm
Victoza
Lyxumia
Novo Nordisk
Sanofi
diabetes
GLP-1 agonist
Novo jumping into phase III trials for major oral diabetes candidate
BioPharma Dive
Thu, 08/27/15 - 11:36 am
Novo Nordisk
diabetes
semaglutide
GLP-1 agonist
Novo Nordisk looks past blockbuster Victoza with PhIII success for weekly GLP-1 med
Fierce Pharma Marketing
Tue, 07/14/15 - 10:41 am
Novo Nordisk
diabetes
Victoza
semaglutide
GLP-1 agonist
Novo Nordisk's new GLP-1 diabetes drug hits goal in trial
Yahoo/Reuters
Sat, 07/11/15 - 10:25 am
Novo Nordisk
GLP-1 agonist
diabetes
semaglutide
Expect Novo Nordisk To Commit To Their Late-Stage Diabetes Pill Development Soon
Seeking Alpha
Thu, 06/18/15 - 09:18 am
Novo Nordisk
GLP-1 agonist
diabetes
Novo-Nordisk's Oral GLP-1 Diabetes Treatment: An Update
Seeking Alpha
Sat, 02/21/15 - 09:38 am
Novo Nordisk
diabetes
GLP-1 agonist
semaglutide
Infographic – Can Eli Lilly turn up the competitive heat in diabetes?
First Word Pharma
Mon, 09/22/14 - 09:30 am
Eli Lilly
diabetes
Trulicity
GLP-1 agonist
Sanofi Wants to Add Oral GLP-1 to Diabetes Offering
Bloomberg
Wed, 09/17/14 - 08:33 am
Sanofi
GLP-1 agonist
diabetes
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Seeking Alpha
Wed, 04/16/14 - 09:37 am
Lyxumia
GLP-1 agonist
Sanofi
Novo Nordisk
diabetes
Victoza
Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co?
Motley Fool
Thu, 03/6/14 - 10:17 am
Eli Lilly
diabetes
patents
dulaglutide
GLP-1 agonist
Novo Nordisk
AstraZeneca
GSK
JNJ
GSK diabetes drug set for European approval
Yahoo/Reuters
Fri, 01/24/14 - 09:36 am
GSK
diabetes
Europe
Eperzan
albiglutide
GLP-1 agonist
This Diabetes Giant Could Face 3 Major Challenges
Motley Fool
Tue, 11/5/13 - 09:57 am
diabetes
Novo Nordisk
Tresiba
GLP-1 agonist
Victoza
New two-hormone Roche drug shows promise in diabetes, obesity
Reuters
Thu, 10/31/13 - 11:29 am
Roche
obesity
diabetes
GLP-1 agonist
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Pages
« first
‹ previous
1
2
3
4
next ›
last »